The Carlyle Group Inc. 4.625% Subordinated Notes due 2061
The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (CGABL) Financial Performance & Income Statement Overview
Explore the financials of The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (CGABL), including yearly and quarterly data on income, cash flow, and balance sheets.
The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (CGABL) Income Statement & Financial Overview
View the income breakdown for The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 CGABL across both annual and quarterly reports.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.84B | $1.83B | $1.07B | $688.40M |
| Cost of Revenue | $2.85B | $1.69B | $681.70M | $479.50M |
| Gross Profit | -$1.01B | $144.00M | $388.00M | $208.90M |
| Gross Profit Ratio | -$0.55 | $0.08 | $0.36 | $0.30 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $153.40M | $176.60M | $187.90M | $147.70M |
| Operating Expenses | $153.40M | $176.60M | $187.90M | $147.70M |
| Total Costs & Expenses | $3.002B | $1.86B | $869.60M | $627.20M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $126.20M | $162.00M | $152.10M | $124.60M |
| Depreciation & Amortization | -$45.30M | $0.00 | $0.00 | $45.30M |
| EBITDA | $329.90M | -$32.60M | $200.10M | $61.20M |
| EBITDA Ratio | $0.18 | -$0.02 | $0.19 | $0.09 |
| Operating Income | -$228.70M | -$32.60M | $200.10M | $61.20M |
| Operating Income Ratio | -$0.12 | -$0.02 | $0.19 | $0.09 |
| Other Income/Expenses (Net) | $494.10M | $821.40M | $18.70M | $59.50M |
| Income Before Tax | $265.40M | $788.80M | $218.80M | $120.70M |
| Income Before Tax Ratio | $0.14 | $0.43 | $0.20 | $0.18 |
| Income Tax Expense | $38.10M | $173.10M | $69.50M | $21.90M |
| Net Income | $210.90M | $595.70M | $148.20M | $65.60M |
| Net Income Ratio | $0.11 | $0.33 | $0.14 | $0.10 |
| EPS | -$2.26 | $1.67 | $0.41 | $0.18 |
| Diluted EPS | -$2.20 | $1.63 | $0.41 | $0.18 |
| Weighted Avg Shares Outstanding | $358.58M | $357.69M | $361.40M | $361.40M |
| Weighted Avg Shares Outstanding (Diluted) | $368.02M | $364.79M | $361.40M | $361.40M |
Financial performance has remained strong, with revenue growing from $688.40M in Q1 2024 to $1.84B in Q4 2024. Gross profit continued to perform well, with margins at -55% in the latest quarter. Operating income reached -$228.70M in Q4 2024, holding a steady -12% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $329.90M. Net income dropped to $210.90M, keeping EPS at -$2.26. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan